Trademarkia Logo

Canada

C$
Trademark Search in Canada
ISOMORPHIC LABORATORIES

View On IC.GC.CA

ISOMORPHIC LABORATORIES
ADVERTISED

on 5 Mar 2025

Last Applicant/ Owned by

Isomorphic Labs Limited

280 BishopsgateLondon EC2M 4RB

GB

Serial Number

2208254 filed on 18th Feb 2022

Correspondent Address

CLARK WILSON LLP

900 - 885 WEST GEORGIA STREETVANCOUVER

BRITISH COLUMBIA

CA

V6C3H1

ISOMORPHIC LABORATORIES

Trademark usage description

(1) downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein struc Read More

Classification Information

Class [009]
(1) Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; downloadable computer software applications for designing and developing artificial intelligence technologies, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; computer software, computer programs and computer software algorithms for manipulating received and inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development.

Classification kind code

11

Class [042]
Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development of computing methods, computer software algorithms, computer software, and computer hardware for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; pharmaceutical and medical research; scientific research in the field of protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development in the field of pharmaceuticals and over-the-counter drugs; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific and technical consulting, scientific research, and development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology, all for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer modelling services, namely developing computer models that represent biomolecular processes for use in the development of pharmaceutical drugs; scientific services for analyzing the properties of organic compounds; drug discovery services.

Classification kind code

11

Mark Details

Serial Number

2208254

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 15th Dec 2023		Agent Changed
Submitted for opposition 22
on 12th Dec 2023		Search Recorded
Submitted for opposition 20
on 12th Dec 2023		Examiner's First Report
Submitted for opposition 223
on 12th Dec 2023		Total Provisional Refusal
Submitted for opposition 256
on 10th Jul 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 8th Sept 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 7th Sept 2022		Formalized
Submitted for opposition 1
on 7th Sept 2022		Created
Submitted for opposition 228
on 18th Feb 2022		International Registration
Submitted for opposition 30
on 18th Feb 2022		Filed